A Clinical Study to Determine the Facial Skin Benefits of a Periodic Fasting-Mimicking Diet
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Skin
- Sponsor
- L-Nutra Inc
- Enrollment
- 45
- Locations
- 1
- Primary Endpoint
- Clinical grading of the facial skin
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This single-center, randomized, controlled clinical trial is being conducted to assess the efficacy on facial skin appearance of the Sponsor's 5-day meal kit when consumed monthly for 3 cycles over the course of 71 days by women with mild to moderate dry fine lines, lack of smoothness, uneven skin tone, and lack of radiance on the face.
Detailed Description
Fasting-mimicking diet (FMD) was developed to mimic the metabolic effects of water-only fasting, while providing modest calories and essential nutrients. It consists of 100% natural ingredients, which are generally regarded as safe (GRAS). It is comprised of bars, soups, and beverages aiming to achieve consistent and effective short-term calorie restriction, while providing adequate micronutrients. The study will test the efficacy parameters, including clinical grading scores, Corneometer measurement, and Antera image analysis and subject self-assessment, of consuming the test products in place of other food over a 5 day period, for 3 cycles, over the course of 71 days when compared with baseline scores/values, and when compared to the untreated control.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Female, 35 to 60 years of age.
- •In good general health (physical, mental, and social well-being, not merely the absence of disease/infirmity), according to subject self-report.
- •Having mild to moderate (score of 3-6 according to a modified Griffiths scale,11 where 0=none and 9=severe) scores for the following parameters on the global face: Dry fine lines, Roughness/skin smoothness (visual), Uneven skin tone, Dullness/lack of radiance
- •Having a Body Mass Index in the range of 20-35 at the baseline visit.
- •Having not had any facial treatments in the past 6 months and are willing to withhold all facial treatments during the course of the study including facials, facial peels, photo facials, laser treatments, dermabrasion, botulinum toxin (Botox®), injectable filler treatments, intense pulsed light (IPL), acid treatments, tightening treatments, facial plastic surgery, or any other treatment administered by a physician or skin care professional designed to improve the appearance or firmness of facial skin. Waxing and threading are allowed but not facial laser hair removal.
Exclusion Criteria
- •Having known allergy or sensitivity to food or any component of the meal kit, including nuts, celeriac/celery, oats, and sesame. (Some of the products \[bars\] are processed in a facility where peanuts, eggs, soy, wheat, milk, and shellfish are also present.)
- •Breastfeeding, pregnant, or planning to become pregnant during the study according to subject self-report.
- •Having fasted (abstained from food) or having followed a very restricted food plan (eg, a cleanse or fast mimicking diet)for any period of more than 24 hours in the past 90 days.
- •Having a history of gastric bypass.
- •Having or having a history of a known, suspected, or diagnosed condition of disordered or restricted eating.
- •Currently experiencing menopause or having experienced menopause within the last 12 months.
- •Having a history of skin cancer within the past 5 years.
- •Having a health condition and/or pre-existing or dormant dermatologic disease on the test area/face that the Investigator or designee deems inappropriate for participation or could interfere with the outcome of the study.
- •Having observable sunburn, suntan, scars, nevi, excessive hair, tattoos, or other dermal conditions on the test areas that might influence the test results in the opinion of the Investigator or designee.
- •Having a history of immunosuppression/immune deficiency disorders, organ transplant, or currently using oral or systemic immunosuppressive medications and biologics and/or undergoing radiation or chemotherapy as determined by study documentation.
Outcomes
Primary Outcomes
Clinical grading of the facial skin
Time Frame: Day 0 (baseline) and 71
Clinical grading will be assessed on the indicated location on each subject's face using a modified Griffiths 10-point scale according to the following numerical definitions. Half-point scores may be used as necessary to more accurately describe the skin condition: 1. Skin smoothness (visual), cheeks; 2. Skin smoothness (tactile), cheeks; 3. Dry fine lines, global face; 4. Clarity, global face; 5. Redness, global face; 6. Evenness of skin tone, global face; 7. Radiance, global face; 8. Overall appearance of skin condition (health)
Secondary Outcomes
- Clinical grading of the facial skin(Day 0 (baseline) and day 11)
- Facial skin hydration(Day 0 (baseline) and day 71)
- Digital Imaging by VISIA(Day 0 (baseline) and day 71)
- Digital Imaging(Day 0 (baseline) and day 71)
- Digital Imaging for skin roughness(Day 0 (baseline) and day 71)
- Self-assessment(Day 0 (baseline) and day 71)